Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT02758587||Recruiting||Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)||
||Other / Industry||
||59||All||18 Years and older (Adult, Older Adult)||NCT02758587||GN15ON133
|July 4, 2017||May 2019||December 2021||May 2, 2016||March 19, 2018||